Codexis completes obligations under research and development deal with biopharmaceutical firm
Under the agreement, Codexis employed its CodeEvolver protein engineering platform technology to develop a novel enzyme for use in its partner’s preclinical therapeutic development program. “We exceeded the performance
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.